Insider Transactions in Q4 2020 at Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 21
2020
|
Sean F. Moran Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
87,500
-20.02%
|
$87,500
$1.75 P/Share
|
|
Dec 21
2020
|
Sean F. Moran Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
87,500
+16.68%
|
$87,500
$1.4 P/Share
|
|
Dec 18
2020
|
Sean F. Moran Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
53,610
-13.3%
|
$53,610
$1.4 P/Share
|
|
Dec 18
2020
|
Sean F. Moran Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
53,610
+11.74%
|
$53,610
$1.0 P/Share
|
|
Dec 16
2020
|
Sean F. Moran Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
36,923
-9.55%
|
$36,923
$1.32 P/Share
|
|
Dec 16
2020
|
Sean F. Moran Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
36,923
+8.72%
|
$0
$0.17 P/Share
|
|
Nov 11
2020
|
Yuval Cohen Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
4,240
+5.33%
|
$4,240
$1.21 P/Share
|